Parenteral nutrition in the treatment of severe HELLP syndrome with leucoencephalopathy – a case report
Keywords:
HELLP syndrome, parenteral nutrition, haemorrhageAbstract
OBJECTIVE: To report own experience with management of severe form of HELLP syndrome asso ciated with leucoencephalopathy, while the parenteral nutrition was applied.
SUBJECT AND METHOD: 42 ‘years old woman in 32 week of 5 th pregnancy was accepted to hospital because of HELLP syndrome. The cesarean section was performed for pregnancy termination. During intervention, massive haemorrhage and development of DIC syndrome reveled, acute liver and kidneys failure. To obtain hemostasis, Recombinant Vila was applied. Our own observations of the clinical effectiveness of the therapy was described. The patient was managed for 2 days from cesarean section with open abdominal cavity, applying the setonage of peritoneum. MR imaging showed high-density lesions in anterior cerebral regions. During developing anergy with bradycardia and body temperature decrease, the parenteral nutrition was applied- with a quick patient recovery.
CONCLUSIONS: Applying the setonage of peritoneum is effective method of hemostasis in cases of life-threatening abdominal haemorrhagies. Early parenteral nutrition during HELLP syndrome was associated with good patient’s recover. It is recommended to continue observations.
Downloads
References
Dreyfus M, Tissier I, Baldauf J, Ritter J.: HELLP syndrome: Review and update, J Gynecol Obstet Biol Reprod. 1997; 26: 9–15
Waterstone M, Bewley S, Wolfe C.: Incidence and predictors of severe obstetric morbidity case-control study. BMJ. 2001; 5, 322: 1089–1094
Sibai AM, Sen K.: Can Lebanon conjure a public health phoenix from the ashes? BMJ. 2006; 21, 333: 848
Pajak J, Heimrath J, Hirnle L,Golebiowski T, Dawidowicz D.: HELLP syndrome: problems in diagnosis and treatment illustrated on the basis of the fully symptomatic case, Ginekol Pol 2000; 71:292–7
Liu CM.: Hepatic rupture caused by HELLP syndrome? Am J Obstet Gynecol. 2007 196,4:16.
Swirkowicz M, Kornacka M, Dadalska E, Czajkowski K.: Newborn of a mother with HELLP syndrome, Ginekol Pol 2004; 75(8): 589–94.
Clenney TL, Viera AJ.: Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome, BMJ. 2004; 31, 329: 270–272.
Peng W X, Nakaii M, Matsushima T, Asakura H.: Atypical case of reversible posterior leucoencephalopathy syndrome associated with puerperal HELLP syndrome, Arch Gynecol Obstem. 2008; 2, 253–264.
Hincz P, Bielak A, Borowski D.: The use of steroids in the treatment of HELLP syndrome-case report, Ginekol Pol 2007; 78: 245–7.
Stefanowicz M, Lipinska J, Stefanowicz E, Malarkiewicz J.: Changes in brain tissue resulting from the HELLP syndrome verified by CT examination, Ginekol Pol 1995; 66:185–7.
CRAWFORD M.: Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants, Am J Clin Nutr 2000;71:275S–84S.
Chalisova N I, Pennijainen VA, Haase G.: Regulating role of various amino acids in development of apoptosis in organotypic culture of the nervous and lymphoid tissue, Ross Fiziol Zh Im I M Sechenova. 2002; 88,5: 627–3313.
Lerebours E, Rimbert A, Hecketsweiler B, Hellot MF, Denis P, Colin R.: Comparison of the effects of continuous and cyclic nocturnal parenteral nutrition on energy expenditure and protein metabolism, JPEN J Parenter Enteral Nutr. 1988; 12,4: 360–4.
Kochevar M, Guenter P, Holcombe B, Malone A, Mirtallo J.: ASPEN statement on parenteral nutrition standardization, JPEN J Parenter Enteral Nutr. 2007; 31,5: 441–8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2009 Medical Journal of the Rzeszow University
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
